April 11, 2023 Comments Off on New patent expiration for Celgene drug REVLIMID Posted in: Uncategorized
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
The post New patent expiration for Celgene drug REVLIMID appeared fi…
April 9, 2023 Comments Off on New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Astrazeneca Ab drug BYDUREON BCIS…